Skip Navigation

This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wilke, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilke, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 53, 156 (2000)
Copyright © 2000 by the Society of Toxicology

LETTER TO THE EDITOR

Russell A. Wilke

Mayo Clinic 200 First Street SW Rochester, Minnesota 55905 wilke.russell{at}mayo.edu

To the Editor:

I recently read with enthusiasm your commentary on the role of MD/PhD's in science (Philip G. Watanabe, 49, 165). I originally trained in an MSTP program, and I have just finished a medicine residency in the University of Wisconsin's Clinical Investigator Track. I am now a senior research fellow at the Mayo Clinic, where I hope to establish myself as an independent investigator. As a young MD/PhD, I cannot thank you enough for vocalizing our plight so eloquently.

Although I began my combined degree training with great enthusiasm, I have spent much of the past 10 years wondering how I would eventually blend patient care and basic science research. It seems that many academic physicians (MD's) have viewed me (an MD/PhD) as less than a complete clinician. Likewise, most basic scientists have viewed my commitment to research as "dilute" due to my dual allegiance. (In fact, I have often wondered if the MSTP didn't sell me a bridge back when I began training in 1988.) If the academic community is not going to embrace MD/PhD's as true investigators, then why is NIH creating them?

As an MD with a PhD in Pharmacology and Toxicology, I now find myself attempting to carve out a niche in the area of clinical toxicology. Although I am board eligible in Internal Medicine, I am not inclined to pursue further clinical training in a traditional medical subspecialty. Rather, I hope to continue my work as a basic scientist, while obtaining experience as a consulting toxicologist in Mayo's Section of Preventive Medicine.

I am particularly interested in derangements of neuroendocrine function (see J. Physiol. 517, 391, J. Biol. Chem. 274, 18387). I have been wrestling for some time with the decision whether or not to pursue a career in clinical toxicology. Your commentary in Toxicological Sciences has injected me with a renewed sense of optimism. It is encouraging that scientists such as yourself have established successful careers by pursuing similar interests.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wilke, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilke, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?